Buch, Englisch, 216 Seiten, Format (B × H): 156 mm x 233 mm, Gewicht: 384 g
Buch, Englisch, 216 Seiten, Format (B × H): 156 mm x 233 mm, Gewicht: 384 g
ISBN: 978-0-443-07240-6
Verlag: Elsevier Health Sciences
This introductory textbook of pharmacoeconomics is ideal for all those working in, aspiring to work in or interested in the pharmaceutical industry. It assumes no prior knowledge of this subject but is written at a level appropriate, for example, for those studying for a postgraduate degree or diploma in pharmaceutical medicine and who already have a first degree in science or medicine. - Emphasizes how pharmacoeconomics can be of assistance in "real world" decision making.
- Covers the development of insuring, financing and delivery of health care in the developed world and the increasing role of governments.
- Explains the trend towards the critical scrutiny of health service activity.
- All topics explained assuming no specialist knowledge.
Zielgruppe
Those starting to work in or aspiring to work in the pharmaceutical industry, typically taking an MSc or similar degree in pharmaceutical medicine or related subject. Sales will be to individuals, as recommended textbooks on courses and to training departments of pharmaceutical companies.
A subsidiary market is to Schools of Pharmacy for library purchase.
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Präventivmedizin, Gesundheitsförderung, Medizinisches Screening
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Public Health, Gesundheitsmanagement, Gesundheitsökonomie, Gesundheitspolitik
Weitere Infos & Material
Basics of economics, health economics and pharmacoeconomics. The policy context for pharmacoeconomics. The economics of health care and health care systems. Pharmacoeconomics: an industry perspective. Disease management and programme budgeting and marginal analysis. Cost of illness studies. Approach to pharmacoeconomic analysis. Pharmacoeconomics and clinical trials. Modeling in health economics. Quality assurance in pharmacoeconomic analyses. Future directions.
